Enhancing the Wnt/β-catenin/TCF4 pathway can increase arrhythmia susceptibility by suppressing Nav1.5 expression, leading to arrhythmias during the acute phase of myocardial infarction (MI), while chronic remodeling occurs in later phases. Here, TCF4 is linked to myocardial infarction.